Cypress Bioscience Prosorba Rheumatoid Arthritis Trial Gets HCFA Nod
This article was originally published in The Gray Sheet
Executive SummaryUnpublished information generated in Cypress Bioscience's Prosorba clinical trial for rheumatoid arthritis was instrumental in the Health Care Financing Administration's decision to cover treatment for the Medicare population.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.